<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0015">
 <label>15</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Roth</surname>
    <given-names>GJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Heckel</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kley</surname>
    <given-names>JT</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Design, synthesis and evaluation of MCH receptor 1 antagonists-Part II: optimization of pyridazines toward reduced phospholipidosis and hERG inhibition</article-title>. 
  <source>Bioorg. Med. Chem. Lett</source>
  <year>2015</year>;
  <volume>25</volume>:
  <fpage>3270</fpage>–
  <lpage>4</lpage>.
  <pub-id pub-id-type="pmid">26077492</pub-id>
 </mixed-citation>
</ref>
